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Abstract 
Background: “There is no free here,” the words of a Malian husband, illustrate how perceptions of cost can deter 
uptake of intermittent preventive treatment of malaria in pregnancy (IPTp). The Malian Ministry of Health (MOH) 
recommends a minimum of three doses of IPTp at monthly intervals. However, despite a national policy that IPTp be 
provided free of charge, only 35 % of pregnant women receive at least one dose and less than 20 % receive two or 
more doses.
Methods: This study explored perceptions and experiences of IPTp cost in Mali and their impact on uptake, using 
qualitative interviews and focus groups with pregnant women, husbands and mothers-in-law. Study team members 
also interviewed and observed health workers at four health centres, two in Sikasso Region and two in Koulikoro.
Results: Despite national-level policies, actual IPTp costs varied widely at study sites—between facilities, and visits. 
Pregnant women may pay for IPTp, receive it free, or both at different times. Health centres often charge a lump sum 
for antenatal care (ANC) visits that includes both free and fee-based drugs and services. This makes it difficult for 
women and families to distinguish between free services and those requiring payment. As a result, some forego free 
care that, because it is bundled with other fee-based services and medications, appears not to be free. Varying costs 
also complicate household budgeting for health care, particularly as women often rely on their husbands for money. 
Finally, while health facilities operating under the cost-recovery model strive to provide free IPTp, their own financial 
constraints often make this impossible.
Conclusions: Both actual and perceived costs are currently barriers to IPTp uptake. Given the confusion around cost 
of services in the two study regions, more detailed national-level studies of both perceived and actual costs could 
help inform policy and programme decisions promoting IPTp. These studies should evaluate both quantitatively and 
qualitatively the cost information provided to and understood by pregnant women and their families. Meanwhile, 
unbundling free and fee-based services, making clear that IPTp is free, and ensuring that it is provided at no cost 
could help increase uptake. Free community-based distribution might be another route to increased uptake and 
adherence.
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Background
“There is no free here,” said a Malian husband during a 
focus group in rural Baguinéda village, “you [always] have 
to pay.” The comment-in response to a question about 
antenatal care—highlights one key barrier to the uptake 
of intermittent preventive treatment of malaria in preg-
nancy (IPTp). Officially in Mali, IPTp is provided at no 
cost to the patient. However, inconsistently applied poli-
cies and a systemic need for revenue generation lead to 
hidden charges and both provider and patient confusion 
about precisely what is and what is not free. Many preg-
nant women forego IPTp as a result.
Malaria in pregnancy can lead to premature birth, 
low birth weight, and maternal and neonatal anaemia, 
all conditions associated with increased risk of sponta-
neous abortion, stillbirth, and neonatal and maternal 
death [1, 2]. Given these negative effects, international 
agencies led by the World Health Organization (WHO) 
have developed a three-pronged approach to prevention 
using (1) sulfadoxine-pyrimethamine (SP) for IPTp; (2) 
insecticide-treated bed nets (ITNs); and (3) rapid diag-
nosis and treatment of malaria. Current international 
guidelines call for pregnant women to receive IPTp doses 
at least 1 month apart at their antenatal care visits from 
the start of their second trimester through delivery and 
ideally under directly observed therapy [3]. These guide-
lines also recommend at least four antenatal care visits 
over the course of a pregnancy [3]. As of 2013, the year 
data collection for this study began, the Malian Ministry 
of Health (MOH) guidelines were revised in line with the 
WHO recommendation and stipulate at least three doses 
of IPTp at monthly intervals by directly observed ther-
apy beginning in the second trimester [4]. Despite this 
national policy, only 35 % of pregnant women receive at 
least one dose of IPTp and less than 20 % receive two or 
more doses [5]. Although Malian policy dictates that all 
pregnant women should receive IPTp and other preven-
tive services free of charge, cost remains a barrier to both 
antenatal care (ANC) and IPTp [2, 4].
The cost structure of the Malian health system has 
evolved over recent decades. Beginning in 1989, Mali 
decentralized health services to the community level in 
line with the Bamako Initiative promulgated jointly by 
UNICEF and WHO [6]. Announced in 1987, the Bam-
ako Initiative advocated for decentralization and cost-
recovery as a means of improving health facilities and 
services and standardizing quality of care [7]. In Mali, 
the Bamako Initiative took the form of locally managed 
health facilities, governed by Community Health Associ-
ations (ASACOs) [6, 8]. Supplementing low government 
investment, the ASACO implemented a cost-recovery 
model based on user fees to generate operational rev-
enue. Through this model of community financing, the 
Bamako Initiative aimed to expand access to basic health 
services and ensure equity in the provision of care. Over 
time, however, the policy had the opposite effect: Many 
of the most vulnerable were unable to pay user fees and 
thus unable to access services [8]. Recognition of this 
problem led to a global health strategy reversal abolish-
ing user fees in the early 2000s [9]. Although at the global 
level the Bamako Initiative was ultimately abandoned, in 
Mali the decentralized ASACO model and health facil-
ity dependence on cost-recovery continue. Since health 
centres must still generate revenue to cover their operat-
ing budgets, providing free medication (a major revenue 
source) is at the uncomfortable intersection of central-
level policy and peripheral-level operational reality. This 
study examines how both actual and perceived costs 
serve as barriers to IPTp uptake among women in Mali 
within this post-Bamako Initiative context.
Methods
Study area and population
This study took place August 2013–April 2014 in four 
rural health zones, two in Sikasso and two in Koulikoro. 
These are the two most populous of Mali’s eight regions, 
with 2.6 and 2.4 million inhabitants, respectively [10]. 
The vast majority of inhabitants live in rural areas: 84 % 
in Sikasso, 95 % in Koulikoro. In both regions, malaria is 
endemic, and SP uptake comparable to the national and 
rural figures (Table 1) [5]. Each health zone encompasses 
one or more rural villages served by a common commu-
nity health centre (Centre de Santé Communautaire, or 
CSCOM). Additional data were collected in 2015 from 
key informants at the district and regional levels of both 
the National Malaria Control Programme and the Repro-
ductive Health Programme.
Study design, sampling and data collection
The overall study objective was to identify principal bar-
riers to the uptake of at least two doses of IPTp among 
pregnant women in Mali. To assess these barriers, the 
study used qualitative methods in rural villages within 
each health zone. These included: semi-structured 
in-depth interviews (IDIs), and focus-group discus-
sions (FDGs), ANC observations and record reviews at 
CSCOMs, and key informant interviews (KIIs) at district 
and regional facilities.
Within each health zone, the study team used pur-
posive sampling to recruit participants with a range of 
perspectives on IPTp. Purposive sampling in this con-
text refers to purposively selecting categories of inform-
ants likely to have knowledge about or influence upon 
pregnant women’s uptake of IPTp. Table  2 lists the cat-
egories of participants enrolled in the study and the num-
ber of participants per category. Within each category, 
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individual participants were identified by a combination 
of convenience and snowball sampling [11].
The data collection team included three physicians 
and one sociologist associated with the School of Pub-
lic Health at the University of Sciences, Techniques, and 
Technologies of Bamako plus one doctoral student from 
the Johns Hopkins University Bloomberg School of Pub-
lic Health (author EH) who is fluent in Bambara. Two of 
the University of Bamako team members had extensive 
experience with qualitative interviewing; the other four 
had more limited experience. Prior to beginning data 
collection, University of Bamako team members under-
went 1 week of training in qualitative methods and study 
objectives provided by the principal investigator (SAH) 
and the Hopkins doctoral student. All data collectors 
were female.
IDIs and FGDs were audio-recorded and all participants 
provided oral consent. Interviewers read the oral consent 
form to each participant. In conformity with IRB guide-
lines, the interviewer then signed her own name on the 
form confirming that the participant had consented to 
participation. Interviewers used funnelling, a question-
ing technique that begins with broader questions in order 
to examine whether and how a participant spontaneously 
raises a specific topic of interest (in this case, IPTp) [12]. 
Participants were asked broader questions to elicit sche-
mas of (a) health and illness during pregnancy, (b) disease 
prevention and medications during pregnancy, and (c) 
experiences with ANC. Later, participants were probed 
about more specific topics related to malaria, IPTp, SP and 
long-lasting insecticidal nets (LLINs). During key inform-
ant interviews, data collectors asked district and regional 
health officials about content and implementation of IPTp 
policy and the influence of community and health systems 
on IPTp uptake. IDIs and FGDs were conducted in Bam-
bara, with the exception of some key informants and clini-
cians who preferred French.
The study team recruited a convenience sample of 
five women per CSCOM for ANC observations. Each 
participant provided verbal informed consent for the 
data collector to accompany her and observe her entire 
visit. The data collector completed a structured obser-
vation form covering the patient-provider interaction, 
clinical exam, content of patient counselling, LLIN dis-
tribution if it occurred, and prescription, acquisition, 
and administration of pharmaceuticals. When partici-
pants were referred to the health facility pharmacy to 
fill prescriptions or retrieve medication, a data collec-
tor shadowed the process, confirming paid or free pro-
vision of IPTp by asking the woman and/or verifying 
details on the prescription receipt. Data collectors also 
took unstructured notes detailing the appointment. In 
addition, the team reviewed maternity and pharmacy 
record books at each CSCOM for SP stock and distri-
bution information.
Data analysis
Data analysis was an iterative, collaborative process. 
Interviewers wrote reflective notes following each data 
collection session and discussed developing themes at 
regular debriefing meetings. The sampling strategy and 
interview guides were revised as new questions emerged.
Table 1 Percentage of  pregnant women attending ANC 
and receiving SP during pregnancy in Mali [5]
Total (national) Sikasso region Koulikoro region
% attending at 
least 1 ANC 
visit
74.1
% receiving SP 











Table 2 Data collection by region and type of participant
Koulikoro region Sikasso region Total
In-depth interviews (IDIs) 15 22 37
 Pregnant or breastfeeding 
woman
6 9 15
Midwife or auxiliary nurse 2 2 4
 Pharmacist 2 1 3
 Physician/CSCOM head – 4 4
 ASACO president 1 – 1
 Community health worker 1 1 2
 NGO worker – 1 1
 District official (KII) 3 3 6
 Mayor – 1 1
 Focus group discussions 
(FGDs)
12 14 26
 Elderly women 3 5 8
 Teachers 1 2 3
 Community health 
workers
2 3 5
 Husbands 3 2 5
 Village officials 1 1 2
 Pregnant or breastfeeding 
women
2 – 2
 ASACO – 1 1
Observations
 ANC visit 10 10 20
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Audio recordings of IDIs, FGDs, and KIIs were tran-
scribed into the language in which they were conducted. 
Transcripts in Bambara were subsequently translated 
into French. Primary documents (transcripts and obser-
vation notes) were uploaded into ATLAS.ti (version 7) 
for topical coding [13]. The research team began coding 
inductively and periodically revised the codebook as new 
themes emerged. Data were interpreted through contin-
ued memo writing and debriefing during and beyond the 
coding process [14].
Ethical considerations
Ethical approval was obtained by the Institutional Review 
Boards of the Johns Hopkins Bloomberg School of Public 
Health (#4848) and the University of Bamako: Faculty of 
Medicine, Pharmacy, and Odontology. Prior to data col-
lection, researchers obtained permission from village, 
CSCOM and CSREF leaders as well as informed consent 
from participants.
Results
The study team completed 37 IDIs, 26 FGDs, and 20 
observations. Table  2 shows the breakdown by region 
and type of participant for each method.
Actual and perceived cost as an obstacle to IPTp
Despite Mali’s policy of providing IPTp free to all preg-
nant women, interviews with both women and health 
care providers demonstrate that costs vary widely. In 
focus group discussions, pregnant women would often 
debate about fees and what they were for, citing different 
experiences even at the same health facility. This variabil-
ity even within a single FGD indicated that cost variability 
impacted all women seeking IPTp irrespective of demo-
graphic characteristics. While some women reported 
that they did receive free SP, many reported that SP was 
included in a prescription they would have to pay to fill at 
the health centre pharmacy. Women often did not know 
the costs of individual medications included in prescrip-
tions since the amounts were presented as a lump sum 
at the pharmacy counter as found in both interview and 
focus group settings and in structured observations.
If you buy the medications one by one you can find 
out their price, but they write a prescription and 
send you to the health centre pharmacy to buy them 
where they total the price of all the medications. If 
you have the money you buy the medications. Oth-
erwise, you just buy the priority ones and afterwards 
you can come back and buy the rest […] Even if you 
can’t find drugs for free, if it’s less expensive that 
would make things easier. (30-year-old pregnant 
woman, Koulikoro)
Lump sum totals make it difficult for women and 
their families to decipher which medicines are free and 
which require payments. To determine individual prices 
requires additional probing and negotiation between the 
payer and the pharmacist. Patients may see more familiar 
medications such as vitamins and iron as a priority while 
leaving behind lesser-known medications like SP. Nearly 
all study participants, both male and female, identified 
malaria as a major risk to pregnant women, but only a 
minority spontaneously identified SP as a drug given to 
prevent malaria in pregnancy. In fact, many interviewees 
mentioned that they wished there were a pill pregnant 
women could take to protect them against malaria.
Aware that financial concerns may prevent some 
women from filling ANC prescriptions, some providers 
try to explain that there is no cost for IPTp. As a 32 year-
old Koulikoro midwife explained:
When we prescribe SP, we tell them to go pick it up at 
the pharmacy… But once they have the prescription 
they just go home saying they don’t have the money. 
We tell them, “even if you don’t have the money, go to 
the pharmacy. There is a free prescription there that 
they will give you.” Despite that many of them don’t 
go to the pharmacy and get it.
However, ANC observations revealed that midwives 
and pharmacists were inconsistent about explaining to 
patients that IPTp was free, so it is unclear what propor-
tion of women understood this. The majority of pregnant 
and recently-pregnant respondents reported experiences 
of both paid and free IPTp administration over time. Ini-
tial doses (usually the first and sometimes the second) 
might be provided at no charge during ANC visits, with 
additional treatments provided for a fee. All cost assump-
tions and experiences change, however, in the case of 
stock-outs. During stock-outs, women receive a pre-
scription they must pay to fill at either the health centre 
pharmacy or a separate private pharmacy, even for initial 
doses. Health providers report that while SP stock-outs 
are not a persistent challenge, they do occur and can last 
several months.
Actual costs as an obstacle to attending ANC
Despite the inconsistencies of IPTp and general phar-
maceutical costs, a known and expected expense associ-
ated with pregnancy at health facilities is the purchase of 
an ANC card. At the first ANC visit, a pregnant woman 
pays for her card. The card is then used to track visits and 
health information during the pregnancy. At the time 
of delivery, additional fees are assessed. As noted dur-
ing observations, however, women may incur additional 
costs beyond the ANC card purchase during follow-up 
visits. In some facilities women are expected to pay a 
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small fee at each consultation visit to cover the price of 
gloves or other routine materials needed by the health 
care providers. Additional expenses may be a separate 
lump sum paid during initial ANC visits or periodic 
amounts collected at the start of each visit. Such variable 
fees are often tied to cost recovery efforts to support the 
ongoing operation of the health facility.
ANC card fees, other incidental charges, and delivery 
costs deter women from attending regular ANC visits. 
The previously quoted midwife from Koulikoro summa-
rized the situation:
It’s a money problem because even when pregnant 
women come for their first ANC visit, if we calculate 
out the total including ANC and delivery fees and 
it goes too high they don’t pay at all and they don’t 
come back again.
When explaining ANC, health workers tend to men-
tion the costs associated with the services rather than the 
elements that are free. As a result, some women forego 
both free and fee-based care. Nationally, 75 % of pregnant 
women attend at least one ANC visit but only 55 % ulti-
mately deliver at a health facility [5]. Costs may account 
for a portion of this discrepancy.
Financial decision‑making power within households
Across all study sites, interviewees cite family patriarchs 
as the decision-makers about ANC attendance. Com-
munity members, including pregnant women, state that 
permission to attend ANC appointments and money to 
finance the visits comes from the pregnant woman’s hus-
band, his older brother, or his father. “Once your wife gets 
pregnant, explained one Sikasso husband, “you have to 
prepare for all the expenses.” But “prepar[ing] for all the 
expenses” does not necessarily indicate that a husband 
has agreed in advance to incur them. A woman may have 
to negotiate with her husband or another male relative 
about each ANC visit.
In providing financial support, some men accom-
pany their wives to the health facility and handle finan-
cial transactions directly. This can create an important 
disconnect between costs and the services with which 
they are associated as the men almost never attend the 
counselling sessions, but simply pay at the pharmacy 
once the visit ends. The majority of women enter coun-
selling sessions alone even if accompanied by their hus-
band to the facility. Men have little interaction with the 
health workers during their wives’ pregnancies and often 
do not know the specifics of the counselling, guidance, 
or medications provided. Although the study did not 
elicit specific reasons for husbands’ lack of involvement, 
ANC consultations in Mali are generally considered 
the purview of women—a setting where male partici-
pation would seem unusual. Among the men who do 
not accompany their wives, many take their wives’ pre-
scriptions from the visit and return to the pharmacy 
on their own to pay any fees directly. This finding rein-
forces observations that women often do not know what 
costs are incurred for the services they receive because, 
“it’s our husbands that pay, so we don’t know the price” 
(35-year-old nursing mother in Sikasso). Additionally the 
husbands themselves are not cognizant of what amounts 
they are paying for which medicines. As one husband in 
Sikasso explained, “If you’re educated you can figure out 
the prices on the prescription. They typically just prescribe 
everything together and don’t tell you the different prices 
or products.”
Costs can also create tension within families. One 
observer noted that a husband and wife were visibly 
stressed when filling the prescriptions at the pharmacy—
worried about the number of medications needed and the 
cost to procure them all. This tension can extend beyond 
the health facility, particularly when women are sent to 
ANC visits on their own. The experience of a 40 year-old 
Sikasso mother illustrates the issue:
“At my first and second ANC visits I had to pay by 
other means. When I asked my husband to reim-
burse me, he refused […] another time I had to 
send my daughter to him to ask for money when I 
was in the hospital and he said he didn’t have any 
so I ended up borrowing 5,000 CFA [US2015 $8.37] 
from my mother. Then we had an argument.
The variability of health centre costs combined with 
the uncertainty of financial support from their husbands 
poses an additional obstacle for pregnant women seek-
ing regular ANC. Beyond their husbands, women often 
cited mothers-in-law as arbiters of financial decisions 
related to pregnancy. Women only cited themselves 
when probed further about permission and support in 
the absence of their husbands or mothers-in-law. Despite 
this apparent lack of autonomy, women reported that 
ultimately it was up to them to find the resources to pay 
for their own care—particularly in asking other family 
members for money. A focus group discussion exchange 
from Koulikoro illustrates the situation:
Pregnant woman 1: Lots of husbands don’t give 
money [for ANC]
Pregnant woman 2: Many of the men do not give 
money [for ANC]. We have to find ways for ourselves 
to get treatments by what few means we have.
Pregnant woman 3: Yes, husbands will just tell you 
to go take traditional medicines.
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The difficulty women face in finding alternative sources 
of money to pay for ANC may reduce the frequency and 
level of services that they are able to obtain.
Health facility challenges to providing free SP
Health facilities acknowledge that their efforts to provide 
free SP in line with national policy sometimes fall short. 
“It could be that today we don’t have the means,” com-
mented one ASACO President in Koulikoro. “We like to 
be able to provide [IPTp] for free, but it depends on the 
financial circumstances at the CSCOM.” Since health 
facilities must continue to generate revenue to maintain 
core operations, their ability to provide free IPTp varies 
over time. Ultimately the pricing scheme is left to the dis-
cretion of the ASACO, and practices differ by commu-
nity. Within a given ASACO, a financial shortfall could 
lead to fee increases even for medicines or services that 
are supposed to be free. “Free provision is a challenge,” 
explained one reproductive health manager in Sikasso, 
“its timeliness, permanence and continuity are a real 
problem.” This sort of unpredictability can deter women 
from continuing their IPTp regimen if only their first 
dose is free, or prevent them from taking IPTp at all if the 
costs are too high. “Once [pregnant women] have bene-
fited from free IPTp,” noted one doctor at a referral health 
centre in Sikasso, “they do not take well to paying for it.”
In addition to stocking free SP for IPTp, some health 
facilities also sell it for curative treatment contrary to 
both national policy and international recommendations. 
Apart from going against WHO guidelines for the strict 
use of SP only for IPTp and not as a curative treatment, 
this practice also further contributes to cost complication. 
As noted during observations, women can be mistakenly 
charged for SP doses if the prescription is not explicit or 
the pharmacist does not know that the dosage is intended 
as a free course of IPTp. Observers also documented dif-
ferent understandings about IPTp provision between clin-
ical and pharmacy personnel. Within one health facility, 
for example, the pharmacy staff stated that both the first 
and second doses of IPTp were provided free while clini-
cians indicated that only the first dose was free.
Discussion
Findings from this study show three key ways in which 
costs inhibit IPTp uptake. First, although national policy 
dictates free provision, pregnant women find themselves 
obligated to pay for SP when health facilities provide 
a first dose free but charge for subsequent doses, when 
stock-outs occur, and when pharmacies charge for a pre-
ventive dose as if it were curative. These inconsistencies 
may discourage women from pursuing IPTp because 
they see it as a service that requires payment even in 
cases when it does not. The fact that different health 
workers have different understandings about the pol-
icy further confounds the issue. At a single facility, one 
health worker may tell a pregnant woman that IPTp is 
free while another tells her there is a charge, further con-
tributing to the overall impression that “there is no free 
here, you [always] have to pay.” Second, pregnant women 
often lack independent access to funds and thus rely on 
a husband, older brother-in-law, or other family member 
to pay any ANC-related expenses. Since this other fam-
ily member is unlikely to have attended the ANC con-
sult, he or she is more likely to know the price of a given 
service or medication than to understand its value. This 
may make him or her less inclined to see the expense as 
justified. Third, costs related to pregnancy and childbirth 
may discourage participation even in the free aspects 
of ANC. While most ANC services are free, pregnant 
women must purchase an ANC card at the initial visit 
and pay a fee for in-facility delivery. In between are hid-
den or incidental charges for routine supplies such as 
gloves that the CSCOM operating budget may be unable 
to cover. Prescription bundling adds to the confusion: 
When a pregnant woman arrives at the CSCOM phar-
macy with a list of medications and the pharmacy atten-
dant quotes a single price for the entire list, she and/or 
her husband or other family member may perceive that 
they are paying for IPTp when the charges are for other 
medications. Malians continue to pay out of pocket for 
50  % of all health expenditures, and such costs remain 
important barriers to access [6]. This finding is consist-
ent with the conclusions of a recent single-community 
pilot programme in Mali that providing free drugs is not 
enough to ensure high uptake when user fees remain in 
place [21]. Despite WHO recommendations that IPTp be 
provided by directly observed therapy, the observations 
and accounts of patients filling pharmacy prescriptions to 
obtain SP demonstrate that this is not consistently prac-
ticed in Mali, an issue addressed elsewhere (Hurley et al, 
pers. comm.). Though indirect and opportunity costs 
associated with attending clinic visits were not included 
in our study, they are also well documented as major bar-
riers to care [15–17]. Figure 1 details components of cost 
for facility-based pregnancy care.
It is tempting to recommend elimination of all user fees 
related to pregnancy and childbirth as the most straight-
forward solution. However, such a recommendation 
would only be feasible if the central health system is will-
ing and able to assume the additional costs. CSCOMs and 
CSREFs on their own could not cover these costs under 
the current funding model. Although the Bamako Initia-
tive has been abandoned in favour of what are supposed 
to be more equitable health care provision practices, 
ASACOs and the CSCOMs that they manage continue 
to depend on locally generated revenue. Chronically 
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underfunded, CSCOMs depend upon user fees and phar-
maceutical sales to remain viable [9].
To eliminate user fees as an obstacle to IPTp uptake, 
alternate administration methods may be preferable to 
the current facility-based practices. While the present 
study focuses exclusively on facility-level costs associated 
with IPTp, there are numerous external costs that pre-
vent IPTp uptake. Transportation costs and the opportu-
nity costs of taking time off to visit health centres play a 
significant role in health care access. Direct distribution 
at the community level would, however, largely eliminate 
these external costs as a barrier. Several studies in sub-
Saharan Africa have found that having community health 
workers distribute free SP directly to women significantly 
increased uptake [18–20]. While IPTp was offered free 
of charge both in the facilities and by community health 
workers, the direct provision of service to the women 
at their homes or in their communities had a significant 
impact. Although these studies have shown differing 
impacts on ANC attendance, each has shown that com-
munity-based distribution of SP greatly increases IPTp 
uptake.
Limitations
In the present study, geographic scope was limited to 
only two of Mali’s eight regions. The sample was small, 
purposive, and limited to four CSCOMs and their catch-
ment areas. Statistically, study results are not generaliz-
able beyond the study areas. Nevertheless, though the 
sample was limited and the study team did not collect 
quantitative cost data on IPTp, general findings are in line 
with others studies in sub-Saharan African on the effect 
of cost on care-seeking behaviours [15–17, 21]. Given 
that government subsidies are lowest at the periph-
eral CSCOM level, the cost-recovery burden for these 
facilities is much higher than for referral hospitals and 
regional facilities. Cost recovery does remain an issue 
throughout the system, however, and with decentralized 
services the experiences at the CSCOM level represent 
a crucial touch point between the health system and 
population.
While all interviewers were female, data from both 
female and male FGDs and IDIs were consistent. The 
importance of cost as a barrier to IPTp in Mali is evidenced 
by how frequently it emerged in interviews with pregnant 
women, family members, and health care providers. Addi-
tionally, although data from observations indicated con-
sistent practices within facilities, these were conducted 
over a 1–2 day period at each of the four included facili-
ties. Given the variance in cost experiences reported by 
women in FGDs and IDIs, additional longitudinal observa-
tions would likely reinforce these qualitative findings.
Conclusions and recommendations
Both actual and perceived costs are currently barriers 
to IPTp uptake in Mali. The continuing importance of 
cost-recovery schemes at the community level hamper 
policy efforts to eliminate user fees for priority services. 
Dependent on community financing, community health 
centres (CSCOM) are unable to abolish user fees, relying 
on them for operational revenue.
Given the confusion around cost of services in the two 
study regions, more detailed national-level studies of 
both perceived and actual costs could help inform policy 
and programme decisions promoting IPTp. These studies 
should evaluate both quantitatively and qualitatively the 
Fig. 1 Illustrative facility-based pregnancy care cost components. Total costs incurred within a health facility during pregnancy can be broken 
down into components shown above. While IPTp costs may be included in prescriptions as either a free or paid treatment, this figure highlights the 
varying levels of expenses just within the facility which contributes to the differing perceptions and confusion around costs
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cost information provided by health facilities and phar-
macies to pregnant women and their families. Facility-
level operational research might also unveil innovative 
ways to provide free services and drugs within the exist-
ing cost-recovery system, or identify more effective and 
efficient health financing structures. Free community-
based distribution of SP via health workers would be 
another route for increasing IPTp uptake and adherence, 
as demonstrated in the aforementioned studies [18–20]. 
Such a policy could be particularly useful given the WHO 
guidance supporting monthly IPTp administration by 
directly observed therapy.
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